المؤلفون: Zhang J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Gao J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Jiang S; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Mao J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Chu L; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Chu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Yang X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Li Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Guo T; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Zhou Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Xu D; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China., Hu J; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China., Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Ni J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. nijianjiao8@sina.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. nijianjiao8@sina.com.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China. nijianjiao8@sina.com.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. nijianjiao8@sina.com., Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. fuscczzf@163.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. fuscczzf@163.com.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China. fuscczzf@163.com.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. fuscczzf@163.com.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 04; Vol. 73 (8), pp. 140. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Neoplasm, Residual ; B7-H1 Antigen/antagonists & inhibitors ; Aged, 80 and over ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Incidence ; Neoplasm Metastasis ; Follow-Up Studies ; Retrospective Studies

المؤلفون: Liu A; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Zhang G; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Yang Y; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Xia Y; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Li W; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China., Liu Y; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China., Cui Q; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Wang D; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Yu J; Department of Oncology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. yujianchun2000@163.com.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 04; Vol. 73 (8), pp. 152. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/mortality , Nomograms* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/immunology , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Female ; Male ; Prognosis ; Retrospective Studies ; Middle Aged ; Aged ; Lymphocyte Subsets/immunology ; Adult ; Lymphocyte Count

المؤلفون: Werner RS; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland., Rechsteiner M; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Curioni-Fontecedro A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Weller M; Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Weiss T; Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Regli L; Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland., Le Rhun E; Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland., Mairinger F; Department of Pathology, University Hospital Essen, Essen, Germany., Opitz I; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland., Soltermann A; Pathologie Länggasse, Ittigen, Switzerland.

المصدر: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2024 Jun 03; Vol. 65 (6).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: Germany NLM ID: 8804069 Publication Model: Print Cited Medium: Internet ISSN: 1873-734X (Electronic) Linking ISSN: 10107940 NLM ISO Abbreviation: Eur J Cardiothorac Surg Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/secondary , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Brain Neoplasms*/secondary , Brain Neoplasms*/genetics, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Mutation ; Genetic Profile ; Adult ; Aged, 80 and over ; Prognosis

المؤلفون: Li Y; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China., Zhang Y; Nanfang PET Center, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong Province, China., Guo Z; Department of Thoracic Surgery, Guangzhou Institute of Respiratory Health & China State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou, China., Hou P; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China., Lv J; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China., Ke M; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China., Liu S; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China., Li S; Guangzhou Medical University, Guangzhou, China., Yin W; Department of Thoracic Surgery, Guangzhou Institute of Respiratory Health & China State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou, China., He J; Department of Thoracic Surgery, Guangzhou Institute of Respiratory Health & China State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou, China., Wang X; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China. 71lu@163.com.

المصدر: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Jun 03; Vol. 24 (1), pp. 68. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/surgery , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/pathology , Lung Neoplasms*/surgery , Fluorodeoxyglucose F18* , Positron Emission Tomography Computed Tomography*/methods , Lymphatic Metastasis*/diagnostic imaging , Radiopharmaceuticals* , Neoplasm Staging*, Humans ; Middle Aged ; Male ; Female ; Prospective Studies ; Aged ; Adult ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology

المؤلفون: Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan. Electronic address: yokuma@ncc.go.jp., Shintani Y; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Sekine I; Department of Medical Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Shukuya T; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Takayama K; Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Inoue A; Department of Palliative Medicine, Tohoku University School of Medicine, Miyagi, Japan., Okamoto I; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan., Yamamoto N; Department of Internal Medicine III, Wakayama Medical University Hospital, Wakayama, Japan., Kawaguchi T; Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan., Miyaoka E; Department of Mathematics, Tokyo University of Science, Tokyo, Japan., Yoshino I; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan., Date H; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Jun; Vol. 25 (4), pp. 336-346.e2. Date of Electronic Publication: 2024 Feb 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Protein Kinase Inhibitors*/therapeutic use , Mutation* , Registries*, Humans ; Male ; Female ; Aged ; Middle Aged ; Japan ; Prognosis ; Prospective Studies ; Aged, 80 and over ; Adult ; Survival Rate ; Neoplasm Metastasis ; Tyrosine Kinase Inhibitors ; East Asian People

المؤلفون: Świtlik W; Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland; weronika_switlik@sggw.edu.pl.; Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland., Wyżewski Z; Institute of Biological Sciences, Cardinal Stefan Wyszyński University in Warsaw, Warsaw, Poland., Gregorczyk-Zboroch K; Division of Immunology, Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Warsaw, Poland., Gietler M; Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland., Pudlarz A; Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland., Szewińska J; Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland., Orzechowski S; Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland., Jakieła S; Department of Physics and Biophysics, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland., Szemraj J; Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland.

المصدر: Anticancer research [Anticancer Res] 2024 Jun; Vol. 44 (6), pp. 2445-2451.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: MicroRNAs*/genetics , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Gene Expression Regulation, Neoplastic* , Cell Proliferation*/genetics , 3' Untranslated Regions*/genetics, Humans ; A549 Cells ; Apoptosis/genetics ; SAP90-PSD95 Associated Proteins/genetics ; GTPase-Activating Proteins/genetics ; GTPase-Activating Proteins/metabolism ; Cell Survival/genetics ; Cell Line, Tumor

المؤلفون: McAleese J; Northern Ireland Cancer Centre, Belfast, United Kingdom; Queens University, Belfast, United Kingdom; Royal College of Radiologists, United Kingdom., Drinkwater K; Royal College of Radiologists, United Kingdom. Electronic address: karl_drinkwater@rcr.ac.uk.

مؤلفون مشاركون: Collaborating Author Group

المصدر: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Jun; Vol. 36 (6), pp. e128-e136. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 9002902 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2981 (Electronic) Linking ISSN: 09366555 NLM ISO Abbreviation: Clin Oncol (R Coll Radiol) Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Workload*/statistics & numerical data, Humans ; Female ; Male ; Aged ; Middle Aged ; United Kingdom ; Radiologists/statistics & numerical data ; Medical Audit ; Aged, 80 and over ; Surveys and Questionnaires ; Adult ; Quality Improvement

المؤلفون: Li S; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China., Yu ZS; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China., Liu HZ; Department of Orthopedics, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China., Li SJ; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China., Wang MY; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China., Ning FL; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China., Tian LJ; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.

المصدر: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (11), pp. e7349.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/therapy , Endostatins*/therapeutic use , Endostatins*/administration & dosage , Immunotherapy*/methods , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Lung Neoplasms*/therapy , Neoplasm Staging*, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/administration & dosage ; Bevacizumab/therapeutic use ; Bevacizumab/administration & dosage ; Indoles/therapeutic use ; Quality of Life ; Quinolines/therapeutic use ; Retrospective Studies

المؤلفون: Hu Z; Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.; Department of Oncology, China-Japan Friendship Hospital, Beijing, China., Zheng Y; Department of Oncology, China-Japan Friendship Hospital, Beijing, China.; Beijing University of Chinese Medicine, Beijing, China., Zheng J; Department of Oncology, China-Japan Friendship Hospital, Beijing, China., Wang Y; Department of National Integrated Traditional and Western Medicine Centre for Cardiovascular Disease, China-Japan Friendship Hospital, Beijing, China., Liao J; Department of National Integrated Traditional and Western Medicine Centre for Cardiovascular Disease, China-Japan Friendship Hospital, Beijing, China., Liu Z; Department of Oncology, China-Japan Friendship Hospital, Beijing, China.; Beijing University of Chinese Medicine, Beijing, China., Li J; Department of Oncology, China-Japan Friendship Hospital, Beijing, China.; Beijing University of Chinese Medicine, Beijing, China., Cui H; Department of Oncology, China-Japan Friendship Hospital, Beijing, China.

المصدر: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (11), pp. e7241.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/blood , Body Mass Index* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/blood , Lung Neoplasms*/mortality , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Prognosis ; Treatment Outcome ; Progression-Free Survival ; Cholesterol/blood ; Adult ; Aged, 80 and over ; Obesity/complications

المؤلفون: Iocolano M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Yegya-Raman N; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Friedes C; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Wang X; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Kegelman T; Department of Radiation Oncology, Delaware Radiation Oncology Associates, Christiana Care Health Systems, Newark, Delaware, USA., Lee SH; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Duan L; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li B; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Levin WP; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Cengel KA; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Konski A; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Langer CJ; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Cohen RB; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Sun L; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Aggarwal C; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Xiao Y; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Kevin Teo BK; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., O'Reilly S; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Zou W; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Bradley JD; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Simone CB 2nd; New York Proton Center, New York, New York, USA., Feigenberg SJ; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

المصدر: Cancer [Cancer] 2024 Jun 01; Vol. 130 (11), pp. 2031-2041. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Lung Neoplasms*/pathology , Lung Neoplasms*/therapy , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/mortality , Hospitalization*/statistics & numerical data , Proton Therapy*/methods , Proton Therapy*/adverse effects , Chemoradiotherapy*/methods , Chemoradiotherapy*/adverse effects, Humans ; Female ; Male ; Aged ; Middle Aged ; Retrospective Studies ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/adverse effects ; Lymphopenia/etiology ; Antibodies, Monoclonal